Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

Increased serum levels of lipopolysaccharide & antiflagellin antibodies in diarrhea-predominant IBS

Discussion in 'Other Health News and Research' started by Dolphin, Sep 26, 2015.

  1. Dolphin

    Dolphin Senior Member

    Messages:
    10,733
    Likes:
    28,334
    http://onlinelibrary.wiley.com/doi/10.1111/nmo.12670/abstract

     
    rosie26, aimossy, merylg and 3 others like this.
  2. msf

    msf Senior Member

    Messages:
    3,271
    Likes:
    4,580
    Well, I´m completely unsurprised, but it´s good that someone is doing these studies. Since IBS is so common, hopefully this will cause more treatments to be developed for it, and these should help many of those with ME.
     
    merylg, Valentijn and alex3619 like this.
  3. msf

    msf Senior Member

    Messages:
    3,271
    Likes:
    4,580
    Actually, one part was surprising: the lower levels of sCD14 in the IBS-D group.
     

See more popular forum discussions.

Share This Page